NOV Inc (NOV) concluded trading on Wednesday at a closing price of $12.01, with 4.35 million shares of worth about $52.19 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.27% during that period and on April 23, 2025 the price saw a loss of about -1.23%. Currently the company’s common shares owned by public are about 381.55M shares, out of which, 374.90M shares are available for trading.
Stock saw a price change of 0.00% in past 5 days and over the past one month there was a price change of -20.57%. Year-to-date (YTD), NOV shares are showing a performance of -17.74% which decreased to -35.95% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.84 but also hit the highest price of $21.20 during that period. The average intraday trading volume for NOV Inc shares is 4.90 million. The stock is currently trading -8.05% below its 20-day simple moving average (SMA20), while that difference is down -15.33% for SMA50 and it goes to -24.00% lower than SMA200.
NOV Inc (NYSE: NOV) currently have 381.55M outstanding shares and institutions hold larger chunk of about 103.04% of that.
The stock has a current market capitalization of $4.55B and its 3Y-monthly beta is at 1.32. PE ratio of stock for trailing 12 months is 7.47, while it has posted earnings per share of $1.61 in the same period. Its PEG reads 0.70 and has Quick Ratio of 1.64 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NOV, volatility over the week remained 3.89% while standing at 5.76% over the month.
Stock’s fiscal year EPS is expected to rise by 9.37% while it is estimated to increase by 14.95% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on March 24, 2025 offering an Outperform rating for the stock and assigned a target price of $22 to it. Coverage by Evercore ISI stated NOV Inc (NOV) stock as an In-line in their note to investors on January 15, 2025, suggesting a price target of $18 for the stock. On January 06, 2025, Seaport Research Partners Downgrade their recommendations, while on December 19, 2024, Piper Sandler Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from Citigroup on November 11, 2024.
